Pengju Wang

1.7k total citations · 2 hit papers
73 papers, 1.2k citations indexed

About

Pengju Wang is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Pengju Wang has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Pengju Wang's work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (8 papers) and Acute Myocardial Infarction Research (7 papers). Pengju Wang is often cited by papers focused on Virus-based gene therapy research (9 papers), CAR-T cell therapy research (8 papers) and Acute Myocardial Infarction Research (7 papers). Pengju Wang collaborates with scholars based in China, United Kingdom and United States. Pengju Wang's co-authors include Yimin Dong, Feng Li, Shian Hu, Renpeng Peng, Honglei Kang, Weizhong Ding, Yaohe Wang, Xiaozhu Li, Shengdian Wang and Nicholas R. Lemoine and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Pengju Wang

67 papers receiving 1.2k citations

Hit Papers

Spinal Cord Injury: The Global Incidence, Prevalence, and... 2022 2026 2023 2024 2022 2024 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengju Wang China 19 367 275 232 207 159 73 1.2k
Jisun Paik South Korea 22 514 1.4× 109 0.4× 254 1.1× 223 1.1× 274 1.7× 90 1.4k
YJ Kim South Korea 24 425 1.2× 251 0.9× 81 0.3× 50 0.2× 243 1.5× 76 1.7k
Ming Zhong China 24 684 1.9× 169 0.6× 123 0.5× 60 0.3× 189 1.2× 143 1.9k
Xing Cheng China 23 390 1.1× 324 1.2× 113 0.5× 80 0.4× 400 2.5× 88 2.3k
José Sánchez‐Corona Mexico 25 576 1.6× 217 0.8× 504 2.2× 110 0.5× 299 1.9× 152 2.0k
Rafael Valdés‐Mas Spain 15 1.1k 2.9× 197 0.7× 233 1.0× 350 1.7× 76 0.5× 23 1.8k
Pavlos Lelovas Greece 17 339 0.9× 128 0.5× 88 0.4× 132 0.6× 248 1.6× 50 1.3k
Takahiro Satoh Japan 27 323 0.9× 241 0.9× 102 0.4× 263 1.3× 210 1.3× 129 2.2k
Chunyan He China 21 601 1.6× 158 0.6× 229 1.0× 65 0.3× 64 0.4× 77 1.5k

Countries citing papers authored by Pengju Wang

Since Specialization
Citations

This map shows the geographic impact of Pengju Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengju Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengju Wang more than expected).

Fields of papers citing papers by Pengju Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengju Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengju Wang. The network helps show where Pengju Wang may publish in the future.

Co-authorship network of co-authors of Pengju Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pengju Wang. A scholar is included among the top collaborators of Pengju Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengju Wang. Pengju Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Meng, Honglei Kang, Yimin Dong, et al.. (2025). Methyl-CpG-binding domain 2 mitigates osteoarthritis through Steap3 promoter methylation and chondrocyte ferroptosis regulation. Experimental & Molecular Medicine. 57(11). 2629–2642.
2.
Xu, Zijian, Yong Zhang, Jingrong Wang, et al.. (2024). The light-responsive transcription factor SlBBX20 improves saline-alkali resistance of Solanum lycopersicum by affecting photosynthetic capacity, antioxidant capacity, and osmotic adjustment. Environmental and Experimental Botany. 224. 105818–105818. 3 indexed citations
3.
Xu, Ning, Jiale Zou, Pengju Wang, et al.. (2024). PRP improves the outcomes of autologous skin graft transplantation on the esophagus by promoting angiogenesis and inhibiting fibrosis and inflammation. Journal of Translational Internal Medicine. 12(4). 384–394. 1 indexed citations
4.
Peng, Renpeng, Yimin Dong, Meng Zheng, et al.. (2024). IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism. Cell Death and Disease. 15(2). 111–111. 20 indexed citations
5.
Wang, Pengju, et al.. (2024). Engineering Escherichia coli for utilization of PET degraded ethylene glycol as sole feedstock. SHILAP Revista de lepidopterología. 17(1). 121–121. 5 indexed citations
6.
Chai, Ningli, et al.. (2023). Clinical Characteristics and Endoscopic Management of Duodenal Lipomas: 10-Year Experience from a Tertiary Center in China. The Turkish Journal of Gastroenterology. 34(7). 720–727. 1 indexed citations
7.
Guo, Yuduo, Weihai Ning, Yujia Chen, et al.. (2023). Oncolytic virus Ad-TD-nsIL-12 inhibits glioma growth and reprograms the tumor immune microenvironment. Life Sciences. 336. 122254–122254. 7 indexed citations
8.
Hou, Guiqin, et al.. (2023). NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinoma. Biochemical Pharmacology. 218. 115920–115920. 5 indexed citations
9.
Wang, Yanru, et al.. (2023). Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy. Frontiers in Immunology. 14. 1126969–1126969. 12 indexed citations
10.
Wang, Pengju, Qing Yao, Xiaosong Yang, et al.. (2023). Resveratrol protects against deoxynivalenol-induced ferroptosis in HepG2 cells. Toxicology. 494. 153589–153589. 24 indexed citations
11.
Ding, Weizhong, Shian Hu, Pengju Wang, et al.. (2022). Spinal Cord Injury: The Global Incidence, Prevalence, and Disability From the Global Burden of Disease Study 2019. Spine. 47(21). 1532–1540. 235 indexed citations breakdown →
12.
Hu, Shian, Pengju Wang, Yimin Dong, & Feng Li. (2022). Incidence, prevalence and disability of spinal cord injury in China from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019. European Spine Journal. 32(2). 590–600. 16 indexed citations
13.
Guo, Xiangqian, et al.. (2022). miR-542-3p reduces antioxidant capacity in goat caput epididymal epithelial cells by targeting glutathione peroxidase 5 (GPx5). Theriogenology. 186. 168–174. 7 indexed citations
14.
Peng, Yong, Hua Wang, Fei Chen, et al.. (2016). The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study. Cardiovascular Diabetology. 15(1). 106–106. 10 indexed citations
15.
Peng, Yong, Hua Wang, Yiming Li, et al.. (2016). Relation between admission plasma fibrinogen levels and mortality in Chinese patients with coronary artery disease. Scientific Reports. 6(1). 30506–30506. 20 indexed citations
16.
17.
Huang, Bao‐Tao, Fang‐Yang Huang, Zhi‐Liang Zuo, et al.. (2015). Target lesion calcification and risk of adverse outcomes in patients with drug-eluting stents. Herz. 40(8). 1097–1106. 6 indexed citations
19.
Wang, Yaohe, Rathi Gangeswaran, Pengju Wang, et al.. (2009). CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. Journal of Clinical Investigation. 119(6). 1604–1615. 26 indexed citations
20.
Wang, Wei, Lexun Xue, Hongtao Liu, et al.. (2009). Aberrant Changes of Wnt2/β-Catenin Signaling Pathway Induced by Sodium Nitroprusside in Human Esophageal Squamous Cell Carcinoma Cell Lines. Cancer Investigation. 28(3). 230–241. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026